Positive Predictive Value of Fecal Occult Blood Testing in Persons Taking Warfarin

Bini, Edmund J.; Rajapaksa, Roshini C.; Weinshel, Elizabeth H.
July 2005
American Journal of Gastroenterology;Jul2005, Vol. 100 Issue 7, p1586
Academic Journal
BACKGROUND : In clinical practice, some physicians discontinue warfarin prior to fecal occult blood testing (FOBT). Although anticoagulant use is associated with an increased risk of overt gastrointestinal bleeding, the impact of warfarin on the positive predictive value of FOBT is unknown. METHODS : During a 5-yr period, we prospectively studied all patients taking warfarin who were referred for the evaluation of a positive FOBT. For each patient taking warfarin, we enrolled one age- and gender-matched control subject with a positive FOBT who was not taking anticoagulants. A detailed clinical history was obtained, and all subjects underwent colonoscopy and esophagogastroduodenoscopy. RESULTS : Lesions consistent with occult bleeding were identified in 59.0% of the 210 patients in the warfarin group and 53.8% of the 210 control subjects ( p= 0.27). Although more lesions were identified by colonoscopy in the warfarin group than in control subjects (36.2% vs 25.7%, p= 0.02), there was no difference in the frequency of lesions identified by esophagogastroduodenoscopy (35.2% vs 39.5%, p= 0.43). Overall, adenomas ≥1 cm in diameter (16.2%) and colorectal carcinoma (9.5%) were the most common lesions identified by colonoscopy, while erosive gastritis (15.5%) and erosive duodenitis (11.0%) were the most frequent lesions found by esophagogastroduodenoscopy. Among individuals with colorectal cancer, 83.3% of patients in the warfarin group had early cancers (Dukes' stage A or B) compared with 50.0% of control subjects ( p= 0.046). CONCLUSIONS : Warfarin use did not decrease the positive predictive value of FOBT. These findings suggest that warfarin should not be discontinued prior to FOBT. (Am J Gastroenterol 2005;100:1–7)


Related Articles

  • Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Guittet, L.; Bouvier, V.; Mariotte, N.; Vallee, J. P.; Levillain, R.; Tichet, J.; Launoy, G. // British Journal of Cancer;4/21/2009, Vol. 100 Issue 8, p1230 

    We investigated variations in sensitivity of an immunochemical (I-FOBT) and a guaiac (G-FOBT) faecal occult blood test according to type and location of lesions in an average-risk 50- to 74-year-old population. Screening for colorectal cancer by both non-rehydrated Haemoccult II G-FOBT and...

  • Management of Patients Taking Warfarin. Huffman, Grace Brooke // American Family Physician;4/15/2001, Vol. 63 Issue 8, p1628 

    Presents information on a study by B.F. Gage and others who conducted a MEDLINE search to review the pharmacology, initiation and maintenance of warfarin treatment, as well as management of abnormal laboratory results and bleeding complications in persons taking warfarin. Description of the...

  • Colonoscopic evaluation of minimal rectal bleeding in average-risk patients for colorectal cancer. Nikpour, Shahriar; Asgari, Ali Ali // World Journal of Gastroenterology;11/14/2008, Vol. 14 Issue 42, p6536 

    AIM: To assess the prevalence of clinically significant lesions in patients with minimal bright red bleeding per rectum (BRBPR). METHODS: Consecutive outpatients prospectively underwent colonoscopy at Loghman Hakim Hospital, Tehran. Minimal BRBPR was defined as small amounts of red blood after...

  • Colonoscopy in the very elderly: a review of 157 cases. Zerey, Marc; Paton, B. Lauren; Khan, Philip D.; Lincourt, Amy E.; Kercher, Kent W.; Greene, Frederick L.; Heniford, B. Todd // Surgical Endoscopy;Oct2007, Vol. 21 Issue 10, p1806 

    Background: Colonoscopy is currently the best diagnostic modality for evaluating colonic diseases but studies of its use in the very elderly are limited.Methods: A single-institution review of all patients aged 85 years or older who underwent colonoscopy from June 2003...

  • Diagnostic Yield of Colorectal Neoplasia with Colonoscopy for Abdominal Pain, Change in Bowel Habits, and Rectal Bleeding. Neugut, Alfred I.; Garbowski, Gail C.; Waye, Jerome D.; Forde, Kenneth A.; Treat, Michael R.; Tsai, June L.; Won Chul Lee // American Journal of Gastroenterology;Aug1993, Vol. 88 Issue 8, p1179 

    Objectives: To assess the clinical yield of colonoscoping in patients who present with rectal bleeding, persistent abdominal pain, or change in bowel habits in the absence of bleeding. Design: A prospective study of colonoscopy patients. Setting: Three colonoscopy practices in New York City...

  • Aspirin/clopidogrel.  // Reactions Weekly;4/11/2009, Issue 1247/1248, p7 

    The article describes the case of a 57-year-old woman who developed occult haemorrhage from a previously undiagnosed colon cancer while being treated with aspirin and clopidogrel for anticoagulation. The woman underwent angioplasty with coronary stenting and started receiving aspirin and...

  • A bridge too far? Heparin increases bleeding during temporary warfarin cessation. Lindsay, Alistair // Heart;May2008, Vol. 94 Issue 5, p676 

    The article discusses the study of thromboembolism in warfarin cessation. It is implied that patients are often asked to refrain from taking warfarin for a short duration while they undergo an elective procedure such as ophthalmic surgery and colonoscopy because of the risk of thromboembolism...

  • Can the colour of per-rectal bleeding estimate the risk of lower gastrointestinal bleeding caused by malignant lesion? Lai, Pui-Yan; Chan, Kin-Wai; Luk, Wan; Wong, Carlos; Meng, William // International Journal of Colorectal Disease;Feb2016, Vol. 31 Issue 2, p335 

    Purpose: To estimate the risk of lower gastrointestinal bleeding (LGIB) caused by malignant lesion in patients presenting with per-rectal bleeding (PRB), by using visual aid as an objective measurement of PRB colour. Methods: This was a prospective observational study on patients presented with...

  • CT colonography accurate in those at high risk for colorectal cancers.  // Hem/Onc Today;7/10/2009, Vol. 10 Issue 13, p27 

    This article discusses a study which examined the use of computed tomographic (CT) colonography as an alternative to colonoscopy in patients with a history of adenoma and those with a family history of colorectal neoplasm.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics